- Open-label, dose-titration tolerability study of atomoxetine hydrochloride in Korean, Chinese, and Taiwanese adults with attention-deficit/hyperactivity disorder. Asia-Pacific Psychiatry. online: 2012.

- Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter Trial. Clin Psychopharmacol Neurosci. 2012.

- Psychological characteristics of early remitters in patients with panic disorder. Psychiatry Res. 2012.

- Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial. Hum Psychopharmacol. 2011.

- A validation study of the Korean version of SPAN. Yonsei Med J. 2011.

- Relationship between Personality and Insomnia in Panic Disorder Patients. Psychiatry Investig. 2011

- Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea. Psychiatry Clin Neurosci. 2010

- Health service utilization in patient with major depressive disorder experiencing significant somatic symptoms in Korea. Int J Disabili Hum Dev. 2010

- Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial. Psychiatry Res. 2009.

- Changes of functional MRI findings in a patient whose pathological gambling improved with fluvoxamine. Yonsei Med J. 2009.

- Revised Korean medication algorithm for bipolar disorder. World J Biol Psychiatry. 2009

- Shorter dinucleotide repeat length in the DRD5 gene is associated with attention deficit hyperactivity disorder. Psychiatr Genet. 2009

- Reliability and validity of the Korean version of the Impact of Event Scale-Revised. Compr Psychiatry. 2009

- Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter,
prospective, naturalistic, open-label trial. Prog Neuropsychopharmacol Biol Psychiatry. 2009